Evaluation of the poly(ADP-ribose) polymerase gene in human stroke

Atherosclerosis

Volumn 148, Issue 2, 2000, Pages 345-352

  Kato, Norihiro ^a   Morita, Hiroyuki ^b   Sugiyama, Takao ^c   Kurihara, Hiroki ^b   Tsubaki, Shin ichi ^d   Nabika, Toru ^e   Kitamura, Kazuyuki ^d   Yamori, Yukio ^a   Yazaki, Yoshio ^b  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c INSTITUTE FOR ADULT DISEASES   (Japan)

^d Kitamura Neurosurgery Clinic   (Japan)

^e SHIMANE UNIVERSITY   (Japan)

Author keywords

Association; Nitric oxide; Polymorphism; Stroke; Susceptibility

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PEROXYNITRITE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA FLANKING REGION; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; PRIORITY JOURNAL; PROMOTER REGION; STROKE;

ADULT; AGED; ALLELES; BASE SEQUENCE; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, GENETIC; REFERENCE VALUES;

EID: 0033968259     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00284-1     Document Type: Article

References (39)

1. de Faire U., Friberg L., Lundman T. Concordance for mortality with special reference to ischaemic heart disease and cerebrovascular disease: a study on the Swedish Twin Registry. Prev. Med. 4:1975;509-517.
2. Brass L.M., Isaacsohn J.L., Merikangas K.R., Robinette C.D. A study of twins and stroke. Stroke. 23:1992;221-223.
3. Kiely D.K., Wolf P.A., Cupples L.A., Beiser A.S., Myers R.H. Familial aggregation of stroke: the Framingham Study. Stroke. 24:1993;1366-1371.
4. Graffagnino C., Gasecki A.P., Doig G.S., Hachinski V.C. The importance of family history in cerebrovascular disease. Stroke. 25:1994;1599-1604.
5. Marmot M.G., Poulter N.R. Primary prevention of stroke. Lancet. 339:1992;344-347.
6. Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts. Lancet. 346:1995;1647-1653.
7. Classification of cerebrovascular disease III. Stroke. 21:1990;637-676.
8. Molinari G.F. Why model strokes? Stroke. 19:1988;1195-1197.
9. Ginsberg M.D., Busto R. Rodent models of cerebral ischemia. Stroke. 20:1989;1627-1642.
10. Garthwaite J., Charles S.L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 336:1988;385-388.
11. Huang Z., Huang P.L., Panahian N., Dalkara T., Fishman M.C., Moskowitz M.A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
12. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
13. Zhang J., Pieper A., Snyder S.H. Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J. Neurochem. 65:1995;1411-1414.
14. Zhang J., Dawson V.L., Dawson T.M., Snyder S.H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263:1994;687-689.
15. Ogura T., Nyunoya H., Takahashi-Masutani M., Miwa M., Sugiyama T., Esumi H. Characterization of a putative promoter region of the human poly(ADP-ribose) polymerase gene: structural similarity to that of the DNA polymerase β gene. Biochem. Biophys. Res. Commun. 167:1990;701-710.
16. de Murcia G., Schreiber V., Molinete M., Saulier B., Poch O., Masson M. et al. Structure and function of poly(ADP-ribose) polymerase. Mol. Cell. Biochem. 138:1994;15-24.
17. + ADP-ribosyltransferase (polymerizing): organization of the gene. DNA. 8:1989;575-580.
18. Berger N.A. Poly(ADP-ribose) in the cellular response to DNA damage. Radiat. Res. 101:1985;4-15.
19. Eliasson M.J.L., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J. et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 10:1997;1089-1095.
20. Oei S.L., Herzog H., Hirsch-Kauffmann M., Schneider R., Auer B., Schweiger M. Transcriptional regulation and autoregulation of the human gene for ADP-ribosyltransferase. Mol. Cell. Biochem. 138:1994;99-104.
21. Fougerousse F., Meloni R., Roudaut C., Beckmann J.S. Dinucleotide repeat polymorphism at the human poly(ADP-ribose) polymerase gene (PPOL). Nucleic Acids Res. 20:1992;1166.
22. Woolf B. On estimating the relation between blood group and disease. Ann. Hum. Genet. 19:1955;251-253.
23. Thompson E.A., Deeb S., Walker D., Motulsky A.G. The detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am. J. Hum. Genet. 42:1988;113-124.
24. Hill W.G. Estimation of linkage disequilibrium in randomly mating populations. Heredity. 33:1974;229-239.
25. Schlesselman J.J., Stolley P.D. Sample size. Schlesselman J.J. Case-control studies. 1982;144-170 Oxford University Press, Oxford.
26. Kessler C., Spitzer C., Stauske D., Mende S., Stadlmuller J., Walther R. et al. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler. Thromb. Vasc. Biol. 17:1997;2880-2884.
27. Schmidt R., Schmidt H., Fazekas F., Schumacher M., Niederkorn K., Kapeller P. et al. Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study. Stroke. 28:1997;951-956.
28. Chen C.H., Lai M.L., Lai M.D., Huang J.D. Apolipoprotein B gene polymorphisms in Taiwanese ischemic stroke patients. J. Formos. Med. Assoc. 96:1997;499-502.
29. Heywood D.M., Carter A.M., Catto A.J., Bamford J.M., Grant P.J. Polymorphisms of the factor VII gene and circulating FVII: C levels in relation to acute cerebrovascular disease and poststroke mortality. Stroke. 28:1997;816-821.
30. Hiramoto M., Yoshida H., Imaizumi T., Yoshimizu N., Satoh K. A mutation in plasma platelet-activating factor acetylhydrolase (Val279-Phe) is a genetic risk factor for stroke. Stroke. 28:1997;2417-2420.
31. Ridker PM, Hennekens CH, Schmitz C, Stampter MI, Lindpaintner K. P1A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis, Lancet 1997;349:385-388.
32. Carlsson L.E., Greinacher A., Spitzer C., Walther R., Kessler C. Polymorphisms of the human platelet antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the platelet receptors for fibrinogen (GPIIb/IIIa), von Willebrand factor (GPIb/IX), and collagen (GPIa/IIa) are not correlated with an increased risk for stroke. Stroke. 28:1997;1392-1395.
33. Longstreth W.T., Rosendaal F.R., Siscovick D.S., Vos H.L., Schwartz S.M., Psaty B.M. et al. Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A). Stroke. 29:1998;577-580.
34. Wagner K.R., Giles W.H., Johnson C.J., Ou C.Y., Bray P.F., Goldschmidt-Clermont P.J. et al. Platelet glycoprotein receptor IIIa polymorphism P1A2 and ischemic stroke risk: The Stroke Prevention in Young Women Study. Stroke. 29:1998;581-585.
35. Markus H.S., Ali N., Swaminathan R., Sankaralingam A., Molloy J., Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke. 28:1997;1739-1743.
36. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry. 64:1998;227-230.
37. Wein K.H., Netzker R., Brand K. Cell cycle-related expression of poly(ADP-ribosyl)transferase in proliferating rat thymocytes. Biochim. Biophys. Acta. 1176:1993;69-76.
38. Mountain J.L., Cavalli-Sforza L. Multilocus genotypes, a tree of individuals, and human evolutionary history. Am. J. Hum. Genet. 61:1997;705-718.
39. Brown M.J. The causes of essential hypertension. Br. J. Clin. Pharmacol. 42:1996;21-27.